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ABSTRACT
Introduction The prevalence of diet- related non- 
communicable diseases (NCDs) are rapidly increasing 
in most parts of the world. In order to ameliorate the 
related public health burden, evidence- informed policies 
to improve diet need to be implemented. Financial 
subsidies that promote healthful consumption patterns 
have the potential to reduce NCD risk and may also reduce 
inequality if targeted at those of low socio- economic 
position. This protocol is for an updated systematic review 
of such evidence.
Methods and analysis A systematic search strategy 
will be used to identify publications on fiscal intervention 
studies indexed in Embase, CINAHL, Web of Science, 
EconLit and PubMed in between January 2013 to February 
2019. Two reviewers will independently sift identified 
citations using prespecified inclusion and exclusion criteria 
to inform full- text review. The outcomes of interest are: 
consumption patterns (% change in targeted items and in 
overall dietary patterns), purchasing patterns (% change) 
or body mass index. Pretested data capture forms will be 
used for double data extraction. Any inconsistencies in 
citation sifting or data extraction will be resolved by a third 
investigator and study authors will be contacted if needed. 
Systematic searches will be supplemented by reference 
checking of key articles. Study quality will be assessed 
and a narrative summary of findings will be produced. 
Meta- analyses and exploration of heterogeneity will be 
completed if appropriate.
Ethics and dissemination The review aims to strengthen 
findings of the primary studies it incorporates. It will 
synthesise existing published aggregated patient data 
and only present further aggregate data. Given this, no 
concerns are held relating to confidentiality and informed 
consent due to re- use of patient data.
If publications or data with ethical concerns are identified, 
they will be excluded from the review.
Results of the systematic review will be published in full 
and authors will engage directly with research audiences 
and key stakeholders to share findings.
PROSPERO registration number CRD42019125013
INTRODUCTION
Non- communicable diseases (NCDs) cause 
over 41 million deaths globally a year, this is 
approximately 71% of all global mortality.1 Of 
the deaths attributable to NCDs, 15 million 
are thought to be preventable, premature 
deaths occurring among those less than 75 
years old. The majority of these preventable, 
premature deaths occur in low- and middle- 
income countries. In high- income countries 
NCDs disproportionately affect individuals 
from low socio- economic backgrounds.2 Non- 
communicable diseases do not only impact 
the adult population. In 2018, an estimated 
40 million children under- five were over-
weight increasing their risk of developing 
an NCD in later life.3 4 The potential future 
health burden due to NCDs is substantial.
Behavioural factors, including unhealthy 
diet, are thought to be responsible for much 
of the increase in prevalence of NCD risk 
factors such as overweight and obesity.5 Given 
diet is modifiable, promoting a healthy diet 
could have a large beneficial impact on the 
prevalence of NCD risk factors and lead to a 
reduction of the burden NCDs place on the 
healthcare system. To aid this, national and 
Strengths and limitations of this study
 ► This review will comprehensively summarise all 
identified quantitative data published on subsidies to 
promote healthful consumption in either a narrative, 
statistical summary or both.
 ► In order to optimise chances of identifying pertinent 
studies, a rigorous search strategy is being used and 
key papers identified will be searched for further rel-
evant references.
 ► If plausible, an exploration of heterogeneity will be 
performed to help identify factors that may be influ-
encing the efficacy of subsidies to promote healthful 
consumption.
 ► The strength of review findings will be highlighted 
using both a publication- centric and an outcome- 
centric evaluation of the evidence it includes.
 ► Although the review aims to be both rigorous and 
comprehensive, it may potentially be constrained by 
the primary data published on the topic. Previous 
findings will only be enhanced if sufficient new high 
quality data has been published.
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global governing health bodies have called for the imple-
mentation of evidence- based policies and transformation 
of the food system in order to make healthy diets acces-
sible to everyone.6–9
A previous systematic review of data published up until 
2014 identified that fiscal levers are effective in promoting 
healthful consumption patterns.1 Since 2014, published 
evidence has rapidly expanded and taxation policies 
have been implemented and scaled up at the local and 
national level.1–5 This planned systematic review will 
update a key component of the prior review, identifying 
a contemporary sample of publications that evaluate the 
effect of subsidies for food or beverages on the following 
outcomes of interest: consumption patterns (% change in 
targeted items and % change in overall dietary patterns), 
purchasing patterns (% change in targeted items and % 
change in non- targeted purchasing patterns) or body 
mass index (BMI, kg/m2).
Prior review findings indicated that there might be 
differences in subsidy efficacy among people of different 
socio- economic status, but were underpowered to draw 
finite conclusions.6 Given this, the outlined review will 
also assess whether subsidy intervention effects are modi-
fied by intervention type or the following characteristics: 
age, sex, socio- economic status, country income level or 
ethnicity.
METHODS AND ANALYSIS
All data will be stored centrally and securely using insti-
tutional servers. The review process will be documented 
as standard and an annotated Preferred Reporting Items 
for Systematic Reviews and Meta- Analyses (PRISMA) flow 
diagram will be produced. The review findings will be 
reported in line with the PRISMA statement.
Search terms equivalent to those set out in the previous 
review of pricing interventions will be used to search 
MEDLINE, EconLit, Embase, CINAHL, Cochrane Library 
and Web of Science from January 2013 until February 
2019 for published fiscal intervention studies.1
As an example, MEDLINE search terms that were used 
have been given below. Search terms for other databases 
can be found in online supplementary appendix 1.
“National”[tiab] OR “Nationwide”[tiab] OR 
“state”[tiab] OR “statewide”[tiab] OR “city”[-
tiab] OR “Workplace”[MeSH Major Topic] OR 
“Workplace”[tiab] OR “Schools”[MeSH Terms] 
OR “School”[tiab] OR “School$“[tiab] OR 
“Supermarket$”[tiab] OR “restaurant$”[tiab] OR 
“fast food”[tiab] OR “store$”[tiab] OR “cafe”[tiab] 
OR “cafeteria”[tiab]
AND
“taxes”[MeSH Terms] OR “tax”[tiab] OR “taxation”[-
tiab] OR “subsidy”[tiab] OR “subsidies”[tiab] OR “in-
centive”[tiab] OR “price”[tiab] OR “pricing”[tiab] 
OR “voucher”[tiab] OR “coupon”[tiab] OR “rebate”[-
tiab] OR “elasticity”[tiab] OR “elasticities”[tiab]
AND
“Food and Beverages”[MeSH Terms] OR 
“fruit”[MeSH Terms] OR “fruit”[tiab] OR “vege-
tables”[MeSH Terms] OR “vegetables”[tiab] OR 
“fat”[tiab] OR “Sugar- sweetened beverage”[tiab] OR 
“soda”[tiab] OR “meat”[tiab] OR “dairy”[tiab] OR 
“candy”[tiab] OR “obesity”[MeSH Terms] OR “obe-
sity”[tiab] OR “BMI”[tiab] OR “body weight”[MeSH 
Terms] OR “sodium, dietary”[MeSH Terms] OR “so-
dium”[tiab] OR “Body Mass Index”[MeSH Major 
Topic] OR “Adiposity”[MeSH Major Topic] OR 
“Adiposity”[tiab] OR “food consumption”[tiab] OR 
“Overweight”[MeSH] OR “Overweight”[tiab] OR 
“calorie”[tiab] OR “calorie$”[tiab]
Where possible, affiliated search engines for online 
databases will be used to store electronic search strings 
and to download all identified citations into EndNote X7. 
Where no affiliated search engine exists, OvidSP will be 
used.
Participants will be generally healthy individuals (chil-
dren or adults), and we will exclude any studies that focus 
only on those with specific illnesses (eg, diabetes mellitus, 
cardiovascular disease). We will not exclude interventions 
targeting those of lower socio- economic status.
Interventions of interest are subsidies that are being 
levied on the final product and that might prevent NCDs 
(eg, food or beverage price reduction via supermarket 
vouchers, or, incentive schemes in canteens to promote 
healthy eating). It is expected that most of the inter-
vention studies in this field will not directly alter price 
but rather offer incentives (eg, vouchers) to increase 
purchases of healthier food such as fruits and vegetables. 
We will include studies of multicomponent interventions 
if the effect of the subsidy alone is discernible or the 
subsidy is the major component of the intervention. We 
acknowledge that some interventions might alter other 
food purchases (ie, those not being subsidised) and that 
some studies may lack reporting of results on overall food 
purchasing and/or consumption patterns, however, we 
will not exclude studies based on these characteristics. No 
exclusion will be made based on intervention setting or 
duration. We will include interventional and observational 
studies that assess the impact of subsidies on patterns of 
purchasing, consumption, participant’s weight or BMI, 
as well as dietary quality and related outcomes. Studies 
will be excluded if they are animal studies, experimental 
studies or modelling studies. We will exclude interven-
tions targeted at providers (eg; shops, schools, caterers) 
rather than consumers. We will exclude interventions 
aimed at snacks alone (eg, subsidies for vending machine 
use). We will not exclude publications based on language, 
year or status. However, studies will be excluded if price 
data is prior to 1990, due to the potential temporality of 
food price variation and consumption.
Initial citation screening will be completed inde-
pendently by two investigators in EndNote X7 using the 
outlined inclusion and exclusion criteria. As needed, 
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publications will be retrieved in full and a prespecified, 
tested Excel form will be used to assess inclusion or exclu-
sion of full- text publications. Where reviewers disagree 
on study inclusion or exclusion, a third independent 
reviewer will be consulted. References of key publications 
identified will be searched for further potential publica-
tions meeting inclusion criteria.
A prespecified, tested Excel form will also be used for 
data extraction including data on study quality and risk 
of bias. Data extraction will be completed independently 
by two investigators and any discrepancies in extraction 
resolved through consultation of a third independent 
reviewer. If at any point in the review process data is 
missing from a primary publication or is unclear study 
authors will be contacted for clarification.
To give a study- centric summary of quality the following 
validated tools will be used: the Newcastle Ottawa Score 
for observational studies,7 and Cochrane Risk of Bias 2 for 
randomised control trials.8 To highlight the consistency 
of evidence contributing to each outcome GRADE, a vali-
dated approach, will be used.9 10 GRADE incorporates its 
own outcome- centric assessment of quality.
Strategy for data synthesis
The characteristics of each study and intervention will be 
collated in a ‘characteristics of included studies’ table. If 
statistical synthesis of results is not appropriate, a struc-
tured report of the effects will be given. Quantitative data 
are likely to be available as aggregate level mean differ-
ences in purchasing, consumption, weight change (as 
defined by each individual intervention study) or BMI. 
If statistical pooling is feasible, a fixed or random effects 
Mantel- Haenszel models will be produced dependent 
on the heterogeneity present between studies (hetero-
geneity will be assessed using the χ2 test, the I2 statistic 
and the prediction interval). Given the broad clinical 
and methodological inclusion criteria it is likely that a 
random effects model will be used. Meta- analyses will 
be completed using Stata 15 with log files of all sessions 
stored. Alternate models will be compared in order to 
identify the model which best portrays the non- linear 
dose response relationships being explored.
Using subgroup analysis or meta- regression, as appro-
priate, potential causes of heterogeneity will be explored 
including; the site of intervention (eg, schools, work-
places, lower income communities, supermarkets), simul-
taneous delivery of additional intervention components 
(eg, education or taxation), mode of delivery (eg, online, 
face- to- face), level of subsidy (as a percentage change in 
price), compliance, adherence, duration of the study and 
its robustness to bias.
Sensitivity analyses will be completed to explore the 
impact on pooled intervention effect estimates of: study 
design, study size, study quality, study duration, study 
setting and of confounders adjusted for, data collection 
methods, withdrawals and drop- outs. Participant charac-
teristics (eg, presence of comorbidities, average baseline 
weight), intervention features and different modes of 
delivery of the intervention (eg, through supermarkets, 
online vouchers or education) will also be noted and 
considered in sensitivity analyses.
Publication bias will be assessed using funnel plots if 
more than 10 studies are being included within a meta- 
analysis; Egger’s test for bias will also be performed.
Patient and public involvement
This review has no element of patient or public 
involvement.
Ethics and dissemination
Given the nature of the systematic review process, ethical 
and safety considerations are minimal. No concerns are 
held relating to the re- use of patient data for new research 
or the need to seek further informed consent. The review 
will collate, synthesise and present previously published 
aggregated patient data. No concerns are held relating to 
patient confidentiality. There are no plans for data depo-
sition or curation.
If publications or data with ethical insufficiency are 
identified by the review, although unlikely, they will be 
excluded.
Any amendments made to the protocol subsequent 
to its publication will initially be highlighted on PROS-
PERO, and indicated with a date. They will then be given 
as a dated addendum to this manuscript.
Findings will be published in a relevant academic 
journal and authors will engage with the wider field 
through academic fora and key stakeholders.
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